A new study may offer a strategy that mitigates negative side effects associated with intravenous injection of nanoparticles commonly used in medicine. The study was published today in Nature Nanotechnology . "Nanotechnology's main advantage over conventional medical treatments is its ability to more precisely target tissues, such as cancer cells targeted by chemotherapy. However, when nanoparticles are injected, they can activate part of the immune system called complement," said senior author Dmitri Simberg, Ph.

https://www.miragenews.com/safer-nanotech-design-possible-new-research-1098253/

#miragenews